Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Dishman Operations In Shanghai Held Up
Reportedly, Dishman had invested around $10m in the Shanghai facility that expands over 40,000sqmt at the Shanghai Chemical Industry Park. The facility will make quaternary salts and intermediates
Reportedly, Dishman had invested around $10m in the Shanghai facility that expands over 40,000sqmt at the Shanghai Chemical Industry Park. The facility will make quaternary salts and intermediates
Ineos ChlorVinyls intends to cease production at its PVC plant at Barry (Wales) and continue to supply customers from its other PVC plants at Runcorn (Cheshire) and Newton
WS Packaging said that FlexWrap labels can be used for different applications, including glass vaccine vials, completely conformable squeeze tubes and any small-diameter structure such as barrel containers
Amylin and Takeda said that the decision to advance the program followed encouraging results from a 52-week blinded, placebo-controlled Phase 2 extension study. The pramlintide/metreleptin combination met the
Ablynx claimed that ALX-0061 binds to the IL-6 receptor (IL-6R). It has a high potency and demonstrated a favourable pharmacodynamic (PD), pharmacokinetic (PK) and safety profile in pre-clinical
The combined business is expected to generate more than $240m of blow molded bottle and injection molded pre-form sales to over 500 customers from 14 manufacturing facilities in
The solution removes a key bottleneck in the current workflow for sequencing by replacing the tedious gel isolation and purification steps used for size selection of sheared genomic
FDA approval of Menveo was based on a Phase III head-to-head clinical trial that compared Menveo to the other US-licensed ACWY meningococcal conjugate vaccine among subjects 11 to
Once-daily Gilenia (0.5mg) has the potential to become the first approved oral therapy for the treatment of multiple sclerosis (MS). As a result of this designation, the standard
Polyphor claimed that the most advanced drug candidate in this new class is POL7080 that selectively kills the dangerous bacteria Pseudomonas aeruginosa. Polyphor has applied its proprietary Protein